MicroMir

Research and Production Center MicroMir (RPC MicroMir) is a biotechnology company founded in 2011 that specializes in the development and production of bacteriophage-based preparations for human health, veterinary medicine, and agriculture. Operating a GMP-compliant manufacturing facility, the company maintains a vast proprietary bacteriophage bank containing over 1,000 virulent phages and 4,500 host bacterial strains. MicroMir's product portfolio includes several marketed phage cocktails designed to selectively target pathogenic bacteria and normalize the microbiome without disrupting beneficial microflora. These products include Phagogyn for intimate hygiene, Phagodent for oral care, Phagoderm for skin health, Otophagus for ENT care, and veterinary formulations like Vetagyn and Phagovet. The company also develops personalized and adaptive phage therapies to combat multidrug-resistant bacterial infections in clinical settings.